361 Capital’s Eli Lilly LLY Stock Holding History

361 Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$836K	Sell	5,095 -939	-16%	-$144K	0.39%	97
2020 Q1	$837K	Buy	6,034 +2,429	+67%	+$334K	0.38%	89
2019 Q4	$474K	Sell	3,605 -278	-7%	-$32.2K	0.13%	278
2019 Q3	$434K	Sell	3,883 -69	-2%	-$7.68K	0.08%	290
2019 Q2	$438K	Sell	3,952 -35	-0.9%	-$4.12K	0.08%	285
2019 Q1	$517K	Sell	3,987 -251	-6%	-$30.5K	0.09%	278
2018 Q4	$490K	Sell	4,238 -18,221	-81%	-$2.04M	0.1%	270
2018 Q3	$2.41M	Buy	22,459 +292	+1%	+$29.2K	0.52%	17
2018 Q2	$1.89M	Sell	22,167 -1,798	-8%	-$148K	0.43%	53
2018 Q1	$1.85M	Sell	23,965 -806	-3%	-$64.9K	0.46%	48
2017 Q4	$2.09M	Sell	24,771 -21,436	-46%	-$1.82M	0.52%	94
2017 Q3	$3.95M	Buy	+46,207	New	+$3.79M	0.76%	25

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

361 Capital's LLY Position: Q2 2020 in Review

361 Capital reduced its Eli Lilly (LLY) stake by 16% in Q2 2020, selling an estimated $144K and leaving 5,095 shares worth $836K. The position accounts for 0.39% of the portfolio, ranked #97.

361 Capital first reported a position in LLY in Q3 2017 and has held it in 12 quarters since. The position peaked at $3.95M in Q3 2017. 1,765 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

361 Capital held 5,095 shares of Eli Lilly worth $836K as of Q2 2020.
361 Capital sold 939 Eli Lilly shares in Q2 2020, an estimated $144K.
Eli Lilly made up 0.39% of 361 Capital's portfolio in Q2 2020, its #97 holding.
361 Capital first reported a position in Eli Lilly in Q3 2017 and has held it in 12 quarters since.
361 Capital's Eli Lilly position peaked at $3.95M in Q3 2017.
1,765 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.